GlassScriptPhysician profile
Callie Corrine Hurtt
NPI 1194187351
$853.77
in general payments reported to CMS, 2019-2025
16 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $87.18 · 2021: $362 · 2022: $179 · 2024: $106 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $190.30 | 2020-2025 | Myosure Tissue Removal Device, Novasure |
| Abbvie INC. | $189.04 | 2021-2022 | |
| Dysis Medical, INC. | $83.23 | 2021 | |
| Astellas Pharma US INC | $67.57 | 2025 | Veozah |
| Daiichi Sankyo INC. | $50.78 | 2021-2022 | |
| Coopersurgical, INC. | $49.60 | 2021-2024 | Paragard T 380a |
| Gilead Sciences, INC. | $45.97 | 2024 | Epclusa |
| Channel Medsystems, INC. | $29.10 | 2022 | |
| Organon LLC | $28.30 | 2024 | |
| Medtronic, INC. | $22.28 | 2022 | |
| Biogen, INC. | $21.17 | 2025 | Zurzuvae |
| Sage Therapeutics, LLC | $19.23 | 2022 | |
| Exeltis, USA INC. | $17.08 | 2024 | Slynd |
| Agile Therapeutics, INC. | $14.02 | 2021 | |
| Lupin INC. | $13.55 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Callie Hurtt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.